Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1☆
To access this article, please choose from the options below
☆ The authors who have taken part in this study have declared a relationship with the manufacturers of the drugs involved and they received funding from the drug companies involved to carry out their research.
PII: S0168-8278(05)00603-3
doi:10.1016/j.jhep.2005.08.020
© 2005 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
